Bacteriology of moderate-to-severe diabetic foot infections and in vitro activity of antimicrobial agents.
about
Staphylococcus aureus Toxins and Diabetic Foot Ulcers: Role in Pathogenesis and Interest in DiagnosisFrom in vitro to in vivo Models of Bacterial Biofilm-Related Infections.Is Clostridium difficile associated with the '4C' antibiotics? A retrospective observational study in diabetic foot ulcer patients.Variation in antibiotic treatment for diabetic patients with serious foot infections: a retrospective observational study.Longitudinal shift in diabetic wound microbiota correlates with prolonged skin defense response.'Does the National Antibiotic Guideline- 2008 remain applicable for treating diabetic foot infection?' A new evidence-based regional study on culture and sensitivity patterns in Terengganu population.Spectrum and prevalence of fungi infecting deep tissues of lower-limb wounds in patients with type 2 diabetes.Choice of wound care in diabetic foot ulcer: A practical approachInter- and intraspecies metabolite exchange promotes virulence of antibiotic-resistant Staphylococcus aureus.Microbiology of diabetic foot infections: from Louis Pasteur to 'crime scene investigation'.New insights in diabetic foot infectionMatrix-assisted laser desorption/ionization time-of-flight mass spectrometry: a new possibility for the identification and typing of anaerobic bacteria.A randomized trial of the efficacy and safety of sequential intravenous/oral moxifloxacin monotherapy versus intravenous piperacillin/tazobactam followed by oral amoxicillin/clavulanate for complicated skin and skin structure infectionsPolymicrobial interactions: impact on pathogenesis and human disease.Analysis of the chronic wound microbiota of 2,963 patients by 16S rDNA pyrosequencing.The microbiome of diabetic foot osteomyelitis.Multicenter study of antimicrobial susceptibility of anaerobic bacteria in Korea in 2012.One step closer to understanding the role of bacteria in diabetic foot ulcers: characterising the microbiome of ulcers.Global fluoroquinolone resistance epidemiology and implictions for clinical use.Microscopy visualisation confirms multi-species biofilms are ubiquitous in diabetic foot ulcers.Efficacy and safety of IV/PO moxifloxacin and IV piperacillin/tazobactam followed by PO amoxicillin/clavulanic acid in the treatment of diabetic foot infections: results of the RELIEF study.Molecular typing, virulence traits and antimicrobial resistance of diabetic foot staphylococciThe bacteriology of diabetic foot ulcers, with a special reference to multidrug resistant strainsAntianaerobic antimicrobials: spectrum and susceptibility testing.Antibiotic resistance in Prevotella species isolated from patients with cystic fibrosisStaphylococcus aureus Shifts toward Commensalism in Response to Corynebacterium Species.Contemporary evaluation and management of the diabetic foot.Molecular diagnosis of Actinomadura madurae infection by 16S rRNA deep sequencing.The treatment of diabetic foot infections: focus on ertapenem.The effect of diabetes mellitus on chronic rhinosinusitis and sinus surgery outcome.Current techniques to detect foot infection in the diabetic patient.Spore-forming Bacilli and Clostridia in human disease.Current medical management of diabetic foot infections.New insights into Prevotella diversity and medical microbiology.Expert opinion on the management of infections in the diabetic foot.Medical management of diabetic foot infections.Resistance surveillance studies: a multifaceted problem--the fluoroquinolone example.From ulcer to infection: an update on clinical practice and adjunctive treatments of diabetic foot ulcers.The microbiome in wound repair and tissue fibrosis.β-Lactamase inhibitors: a review of the patent literature (2010 - 2013).
P2860
Q26741281-1B553460-23C7-471C-ADB6-66552825C857Q30424697-1579F3CB-658C-4D07-B4FE-F0309DD1E51BQ31150390-3A8134E1-AF14-453E-AA2F-47B144223500Q33625956-8784C354-35BE-4F35-8813-8CD4A671998AQ33644153-EF095B6E-2429-4A59-BF42-B52E81E9F04CQ33886496-83D35BC8-5756-481C-9BBE-32BE7F309EFDQ33909419-D411AE25-EC40-411B-BE3E-0DCE9C230059Q34023583-154BA9D4-2C8F-413C-8F92-C50633841C9DQ34339439-9CDF3FC6-ABBD-4788-83EA-F42CF82B2738Q34855203-30AA976A-CA70-41EF-BECA-26D3EDC8D5EBQ34878021-55907462-6720-41A1-989C-D6A1F2C5A4B1Q35103146-FE73F82B-7DF1-48FE-88D0-F624A0846269Q35328383-219FAD83-A06E-4D14-9890-0BF939752859Q35666253-E0C4ABB3-BCC7-49EE-99C0-DEE9DC7EC81DQ35805594-0B816166-1668-403F-88F6-7A8DDB30DD74Q35869503-945863A2-6D52-49BF-A279-939552E6E1A5Q35877303-8B48F524-E865-42C1-9B18-136C82922A2BQ35966819-C17FB5A1-C4B8-47EE-BB5C-B4BCCB86223BQ36337074-E05C1282-7887-4F2C-AA3F-A802D72AE1D7Q36413097-FBCFE4D1-FE67-48A0-BAE5-A6725593AA6DQ36592698-66A8FED5-CDF5-4705-A19A-183C02165807Q36662239-C26B32F6-A3AD-4A30-B1B2-D12980AF7C60Q36740325-659B9FF4-A0A4-42DC-AB69-A9A721E9E3D9Q37035824-68D4EAF7-42DF-48C0-97C1-27B8C0DA4EF7Q37169933-BFDA0B5D-0137-4EC7-9335-8144EA32F3CEQ37182597-3761A3D6-2D81-44BF-8D16-F904E778C19BQ37288217-DC0BA00E-B8EE-4DA3-A5EF-D7D275FD5A7CQ37336147-6B955B6D-7E9D-4939-A2F1-EB42C5BFE636Q37458910-425FB4B0-6321-463C-A098-154C274BB865Q37684648-AC717AF3-9BC0-44C5-85F0-E6C0665F33DDQ37703981-2BBA1B5B-73B9-44E1-8AAB-B70AAB8755BDQ37772894-BE6C3A91-8E82-4673-9DCF-E0770B0428D5Q37809059-822AE42E-9CFD-4347-B56D-25C1820128E5Q37816407-E34EE280-92E0-4AF7-ADA5-7A736CD288A6Q37978287-E8E6DBA7-B165-42AF-BC5D-F17279467551Q37995865-9F1E849A-9CE8-4F0D-BCCA-98367E7FDA14Q37998398-09E42EEB-CF25-4EEE-A89F-E68275A55C48Q38035802-294C8711-0532-41E8-A27C-D11D6CC3929FQ38050078-76290AC3-224D-424A-9EAB-1D1D5F1AE9ADQ38130715-B4D23C9A-EDBE-4830-8C76-5FEF6F0367DD
P2860
Bacteriology of moderate-to-severe diabetic foot infections and in vitro activity of antimicrobial agents.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Bacteriology of moderate-to-se ...... ivity of antimicrobial agents.
@ast
Bacteriology of moderate-to-se ...... ivity of antimicrobial agents.
@en
type
label
Bacteriology of moderate-to-se ...... ivity of antimicrobial agents.
@ast
Bacteriology of moderate-to-se ...... ivity of antimicrobial agents.
@en
prefLabel
Bacteriology of moderate-to-se ...... ivity of antimicrobial agents.
@ast
Bacteriology of moderate-to-se ...... ivity of antimicrobial agents.
@en
P2093
P2860
P356
P1476
Bacteriology of moderate-to-se ...... ivity of antimicrobial agents.
@en
P2093
C Vreni Merriam
Diane M Citron
Ellie J C Goldstein
Murray A Abramson
P2860
P304
P356
10.1128/JCM.00551-07
P407
P577
2007-07-03T00:00:00Z